Valuation: PHARMAGEST INTER.

Market Cap 40Cr 44Cr 37Cr 34Cr 63Cr 4.13TCr 66Cr 449.8Cr 177.8Cr 2.23TCr 165.7Cr 162.23Cr 7.03TCr P/E 2026 *
9.11x
P/E 2027 * 8.32x
Enterprise Value 32Cr 35Cr 29Cr 26Cr 50Cr 3.25TCr 52Cr 354.22Cr 140.02Cr 1.75TCr 130.49Cr 127.75Cr 5.54TCr EV / Sales 2026 *
1.26x
EV / Sales 2027 * 1.1x
Free-Float
31.97%
Yield 2026 *
5.37%
Yield 2027 * 5.53%
Manager TitleAgeSince
Chief Executive Officer 57 22/04/2022
Director of Finance/CFO - 01/01/2023
Chief Tech/Sci/R&D Officer - 01/07/2018
Director TitleAgeSince
Chairman 61 25/06/2026
Director/Board Member 58 16/06/2011
Director/Board Member 57 01/01/2013
Change 5-day change 1-year change 3-year change Capi.($)
-1.11%-7.93%-21.18%+48.06% 22TCr
-2.12%-12.66%-18.46%-15.43% 16TCr
-4.93%-10.32%-5.21%-31.25% 14TCr
+5.66%-4.47%+53.11%+313.28% 10TCr
+2.45%-7.17%+9.87%+67.71% 9.62TCr
-1.13%-3.87%-23.30%-32.06% 9.32TCr
-0.67%-0.27%-3.95%-0.67% 6.86TCr
-1.88%-3.93%-26.45%-22.87% 4.9TCr
-0.81%-4.43%-16.29%+2.72% 3.93TCr
Average +0.14%-2.40%-5.76%+36.61% 11TCr
Weighted average by Cap. -0.00%-2.67%-6.53%+39.30%

Financials

2026 *2027 *
Net sales 25Cr 28Cr 23Cr 21Cr 40Cr 2.58TCr 41Cr 280.84Cr 111.02Cr 1.39TCr 103.46Cr 101.29Cr 4.39TCr 27Cr 29Cr 25Cr 22Cr 42Cr 2.73TCr 44Cr 297.56Cr 117.62Cr 1.47TCr 109.61Cr 107.32Cr 4.65TCr
Net income 4.3Cr 4.71Cr 3.97Cr 3.58Cr 6.75Cr 440.08Cr 7.02Cr 48Cr 19Cr 237.54Cr 18Cr 17Cr 750.07Cr 4.8Cr 5.26Cr 4.44Cr 4.01Cr 7.54Cr 491.82Cr 7.84Cr 54Cr 21Cr 265.47Cr 20Cr 19Cr 838.26Cr
Net Debt -8.56Cr -9.39Cr -7.91Cr -7.14Cr -13Cr -877.08Cr -14Cr -96Cr -38Cr -473.41Cr -35Cr -34Cr -1.49TCr -11Cr -12Cr -10Cr -9.22Cr -17Cr -1.13TCr -18Cr -123.34Cr -49Cr -610.85Cr -45Cr -44Cr -1.93TCr
Logo PHARMAGEST INTER.
Equasens is No. 1 in France for publishing and integrating software programs for pharmacies, hospitals, healthcare facilities, laboratories, retirement homes and healthcare professionals. Net sales break down by activity as follows: - pharmacy software publishing and integration (72.8%): software programs for managing data bases, information, inventories, orders, electronic care records, etc.; - publishing of IT solutions for health and medical/social establishments (15.9%): publishing and integration of software packages for retirement homes, hospitals and care homes (software for managing admissions, billing, receipt and accounting management, care management, supply management, etc.); - development of solutions and infrastructures for e-Health (6.2%): digital communication, telemedicine and telehealth solutions; - software publishing for private practitioners and medical assistants (4.2%); - development of financing solutions for leased goods (0.9%; Nanceo). Net sales are distributed geographically as follows: France (87.5%), Italy (6.1%), Belgium (3%), Germany (2.5%), the United Kingdom (0.8%), and Ireland (0.1%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - PHARMAGEST INTER.